I don't think so and I'm honestly fine with that. Let's just get some LymPro revenue going and move MANF forward and things will take care of themselves.
I have never been impressed by Eltoprazine, so I'm leaving that out. If we get good news there, then all the better.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links